July 14, 2014

Shire announced that the company requested and has received a revised proposal from AbbVie that would value a proposed merger deal at $53 billion.

December 27, 2013

Drug maker Shire is extending the deadline for its offer to buy Exton, Pa.-based ViroPharma for $4.2 billion, Shire said Friday.

November 11, 2013

Shire will pay $4.2 billion to buy a drug maker specializing in treatments for rare diseases.

June 7, 2013

For those suffering from heart or lung disease, cancer, systemic infections or other all-too-common conditions, the science of medicine has made extraordinary advances over the past few decades. But millions of patients afflicted with an uncommon and little-understood disorder often are consigned to the far margins of medical care, in many cases, for years.

February 15, 2013

The Food and Drug Administration has approved a generic drug for attention deficit hyperactivity disorder made by Teva Pharmaceutical Industries, the Israeli generic drug maker said.

January 12, 2012

Prasco Labs will act as the distributor for an authorized generic version of a Shire anticonvulsant drug, the company said Thursday.

January 10, 2012

Shire has acquired U.S. rights to a drug used to treat chronic constipation in women from Johnson & Johnson, the company said Tuesday.

April 6, 2011

British drug maker Shire has filed suit against Watson Pharmaceuticals and subsidiaries, alleging patent infringement in a case concerning a drug used to treat attention deficit hyperactivity disorder.

February 25, 2011

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

November 14, 2010

The Food and Drug Administration has approved an attention deficit hyperactivity disorder drug for use...

September 30, 2010

Shareholders of Belgian drug maker Movetis have put up nearly all of their shares for...

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

August 8, 2010

British drug maker Shire will acquire Belgian drug maker Movetis for $567 million, Movetis said....

March 15, 2010

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...